Navigation Links
MU researchers find missing link in plant defense against fungal disease
Date:4/19/2011

Botrytis bunch rot, a disease caused by the fungal pathogen Botrytis cinerea, can devastate grape vineyards. Yet other plants can repel the invader and protect themselves by mounting a form of chemical warfare against the fungi through the production of antimicrobial substances, called phytoalexins.

Scientists at the University of Missouri report on a discovery in a key component in the signaling pathway that regulates the production of phytoalexins to kill the disease-causing fungus Botrytis cinerea.

"When the mustard plant Arabidopsis detects the fungus Botrytis cinerea, it produces a phytoalexin, called camalexin, in response," said Shuqun Zhang, professor of biochemistry and senior author of the study. "Camalexin acts as sort of an antibiotic against the specific fungus, allowing the plant to successfully defend itself."

In previous work, Zhang and his colleagues showed a signaling pathway, known as MAPK cascade, triggers the transcription activation of genes that make camalexin in Arabidopsis. This study shows that the target of this signaling cascade is the WRKY33 transcription factor.

Arabidopsis plants lacking the gene are unable to synthesize camalexin and are more susceptible to the Botrytis cinerea fungus.

The finding provides an important missing link in the chain of molecules that tells the plant to mount an appropriate defense against an invading microbe.

"Phytoalexins are one important way plants defend themselves naturally against pathogens. Knowing how plants regulate this defense response may allow us to naturally enhance pathogen tolerance in plants," Zhang said.


'/>"/>

Contact: Melody Kroll
KrollMM@missouri.edu
573-884-4144
University of Missouri-Columbia
Source:Eurekalert

Page: 1

Related biology news :

1. New biosensor microchip could speed up drug development, Stanford researchers say
2. Nottingham researchers help bridge the urban and rural divide in the UK and India
3. Researchers discover precisely how thalidomide causes birth defects
4. Researchers get a first look at the mechanics of membrane proteins
5. Jefferson researchers unlock key to personalized cancer medicine using tumor metabolism
6. NIH researchers complete whole-exome sequencing of skin cancer
7. New genetic tool helps researchers to analyze cells most important functions
8. NIH researchers identify cause and new treatment for common recurrent fever in children
9. UMMS researchers develop new technology to screen and analyze genetic mutations
10. Livermore researchers develop battery-less chemical detector
11. Researchers ID microbe responsible for methane from landfills
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... PUNE, India , March 23, 2017 The report ... Equipment, Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by ... growing at a CAGR of 29.63% between 2017 and 2022. ... ... Logo ...
(Date:3/22/2017)... YORK , March 21, 2017 ... Marketing Cloud used by retailers such as 1-800-Flowers ... its platform — Product Recommendations and Replenishment. Using Optimove,s ... give more personalized product and replenishment recommendations to ... but also on predictions of customer intent drawn ...
(Date:3/20/2017)... March 20, 2017 PMD Healthcare announces the ... and Wellness Management System (WMS), a remote, real-time lung ... 2010, PMD Healthcare is a Medical Device, Digital Health, ... dedicated to creating innovative solutions that empower people to ... intent focus, PMD developed the first ever personal spirometer, ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... ... ... USDM Life Sciences , the leading risk management, technological innovation and ... announce Holger Braemer as Vice President of its Europe division and Managing ... , Braemer is an integral part of USDM’s expansion of services and solutions for ...
(Date:4/20/2017)... - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or ... Congress ("ILC") 2017 of the European Association for the Study ... on the positive effects of PBI-4050 on reduction of non-alcoholic ... syndrome. ... Lyne Gagnon, Vice-President of R&D Pre-clinical of Prometic "This extensive ...
(Date:4/20/2017)... ... April 20, 2017 , ... ... unique intellectual property (IP) sharing and commercialization model. , The Center for Advancing ... main component of this effort is bringing the IP to the attention of ...
(Date:4/20/2017)... April 20, 2017 For today, Stock-Callers.com ... novel drug development and clinical research aimed at treating diseases ... (NASDAQ: BSTG), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Kite Pharma Inc. ... ). You can access our complimentary research reports on these ... ...
Breaking Biology Technology: